Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
Journal of Pharmaceutical Sciences
|
December 29, 2005
Factors influencing regional differences in intestinal absorption of UK-343,664 in rat: possible role in dose-dependent pharmacokinetics
Amal Kaddoumi, David Fleisher, Tycho Heimbach, et al.
Biopharmaceutics & Drug Disposition
|
February 17, 2018
Verification of a physiologically based pharmacokinetic model of ritonavir to estimate drug-drug interaction potential of CYP3A4 substrates
Ken-Ichi Umehara, Felix Huth, Christina S Won, et al.
Pharmaceutical Research
|
May 13, 2022
Applications, Challenges, and Outlook for PBPK Modeling and Simulation: A Regulatory, Industrial and Academic Perspective
Wen Lin, Yuan Chen, Jashvant D Unadkat, et al.
Drug Metabolism and Personalized Therapy
|
November 28, 2017
Estimation of fractions metabolized by hepatic CYP enzymes using a concept of inter-system extrapolation factors (ISEFs) - a comparison with the chemical inhibition method
Ken-Ichi Umehara, Felix Huth, Helen Gu, et al.
Journal of Pharmaceutical Sciences
|
June 16, 2018
Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies
Christophe Tistaert, Tycho Heimbach, Binfeng Xia, et al.
Journal of Pharmaceutical Sciences
|
October 22, 2021
Physiologically Based Biopharmaceutics Modeling to Demonstrate Virtual Bioequivalence and Bioequivalence Safe-space for Ribociclib which has Permeation Rate-controlled Absorption
Marc Laisney, Tycho Heimbach, Martin Mueller-Zsigmondy, et al.
The AAPS Journal
|
June 11, 2024
Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space
Michael Wang, Tycho Heimbach, Wei Zhu, et al.
The AAPS Journal
|
April 11, 2018
Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report
Andreas Abend, Tycho Heimbach, Michael Cohen, et al.
Cancer Chemotherapy and Pharmacology
|
April 25, 2012
Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions
Binfeng Xia, Tycho Heimbach, Tsu-han Lin, et al.
Pharmaceutical Research
|
July 15, 2022
Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs
Di Wu, Maitri Sanghavi, Sivacharan Kollipara, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
Journal of Pharmaceutical Sciences
|
December 29, 2005
Factors influencing regional differences in intestinal absorption of UK-343,664 in rat: possible role in dose-dependent pharmacokinetics
Amal Kaddoumi, David Fleisher, Tycho Heimbach, et al.
Biopharmaceutics & Drug Disposition
|
February 17, 2018
Verification of a physiologically based pharmacokinetic model of ritonavir to estimate drug-drug interaction potential of CYP3A4 substrates
Ken-Ichi Umehara, Felix Huth, Christina S Won, et al.
Pharmaceutical Research
|
May 13, 2022
Applications, Challenges, and Outlook for PBPK Modeling and Simulation: A Regulatory, Industrial and Academic Perspective
Wen Lin, Yuan Chen, Jashvant D Unadkat, et al.
Drug Metabolism and Personalized Therapy
|
November 28, 2017
Estimation of fractions metabolized by hepatic CYP enzymes using a concept of inter-system extrapolation factors (ISEFs) - a comparison with the chemical inhibition method
Ken-Ichi Umehara, Felix Huth, Helen Gu, et al.
Journal of Pharmaceutical Sciences
|
June 16, 2018
Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies
Christophe Tistaert, Tycho Heimbach, Binfeng Xia, et al.
Journal of Pharmaceutical Sciences
|
October 22, 2021
Physiologically Based Biopharmaceutics Modeling to Demonstrate Virtual Bioequivalence and Bioequivalence Safe-space for Ribociclib which has Permeation Rate-controlled Absorption
Marc Laisney, Tycho Heimbach, Martin Mueller-Zsigmondy, et al.
The AAPS Journal
|
June 11, 2024
Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space
Michael Wang, Tycho Heimbach, Wei Zhu, et al.
The AAPS Journal
|
April 11, 2018
Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report
Andreas Abend, Tycho Heimbach, Michael Cohen, et al.
Cancer Chemotherapy and Pharmacology
|
April 25, 2012
Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions
Binfeng Xia, Tycho Heimbach, Tsu-han Lin, et al.
Pharmaceutical Research
|
July 15, 2022
Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs
Di Wu, Maitri Sanghavi, Sivacharan Kollipara, et al.
Page
of 9